The China Pharmaceutical Innovation and Invention Index, a new gauge, highlights top drug makers on the mainland for the ...

UCSF buys former FibroGen tower in Mission Bay; dental school could move in with renovations starting in 2026.

Robert Lyne has been named CEO of PureTech Health as the Boston biotech company seeks funding to spin out Celea Therapeutics ...

And what a year it has been! Artificial intelligence is being incorporated into more aspects of our lives, weight-loss drugs ...

A new mental health-driven biotech has arrived in Syremis Therapeutics. | Founded by a team of neuropsychiatric-focused Teva ...

Natural sunscreens shield the skin from harmful radiation, without triggering allergic reactions. In a recently published ...

Partnerships with giants like Eli Lilly and Thermo Fisher Scientific put biotech in the spotlight again, though founders still struggle to find investments in their hometown.

The new saw: Development-stage biotechs are maturing. Their drugs are winning approvals and independent commercial launches ...

Rwanda launches BioCap project to build crop biotechnology capacity Five-year program targets cassava, potato, banana improvement $14 million centre to train scientists in advanced biotech techniques ...

The bank's list of highest-conviction stock picks for 2026 spans numerous sectors and features names including Pepsi and GM.

The investment firm co-led a $125 million Series A round for Ambros Therapeutics, a Vivek Ramaswamy co-founded company with a ...

Vir Biotechnology is handing off certain commercial rights for its hepatitis D program to European specialty pharma Norgine ...